KMDA

Kamada Ltd.

5.43 USD
+0.06 (+1.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kamada Ltd. stock is up 7.52% since 30 days ago. The next earnings date is Aug 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 11 May’s closed higher than April. 100% of analysts rate it a buy.

About Kamada Ltd.

Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to AATD. It also provides Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity.